A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we present a standard pipeline to obtain murine ATC tumors by spontaneous genetically engineered mouse models. Further, we present tumor dynamics and pathological information about the primary and metastasized lesions. This model will help researchers to understand tumorigenesis and facilitate drug discoveries.
Anaplastic thyroid cancer (ATC) is a rare but lethal malignancy with a dismal prognosis. There is an urgent need for more in-depth research on the carcinogenesis and development of ATC, as well as therapeutic methods, since standard treatments are essentially depleted in ATC patients. However, low prevalence has hampered thorough clinical studies and the collection of tissue samples, so little progress has been achieved in creating effective treatments. We used genetic engineering to create a conditionally inducible ATC murine model (mATC) in a C57BL/6 background. The ATC murine model was genotyped by TPO-cre/ERT2; BrafCA/wt; Trp53ex2-10/ex2-10 and induced by intraperitoneal injection with tamoxifen. With the murine model, we investigated the tumor dynamics (tumor size ranged from 12.4 mm2 to 32.5 mm2 after 4 months of induction), survival (the median survival period was 130 days), and metastasis (lung metastases occurred in 91.6% of mice) curves and pathological features (characterized by Cd8, Foxp3, F4/80, Cd206, Ki67, and Caspase-3 immunohistochemical staining). The results indicated that spontaneous mATC possesses highly similar tumor dynamics and immunological microenvironment to human ATC tumors. In conclusion, with high similarity in pathophysiological features and unified genotypes, the mATC model resolved the shortage of clinical ATC tissue and sample heterogeneity to some extent. Therefore, it would facilitate the mechanism and translational studies of ATC and provide an approach to investigate the treatment potential of small molecular drugs and immunotherapy agents for ATC.
Thyroid cancer is one of the most common endocrine malignancies1, originating from the thyroid epithelium. In recent years, the incidence of thyroid cancer has increased rapidly worldwide2. Thyroid cancer can be divided into distinct types according to the degree of tumor cell differentiation. On the basis of clinical behavior and histology, thyroid carcinomas are divided into well-differentiated carcinomas, including papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC), poorly differentiated carcinoma (PDTC), and undifferentiated or anaplastic carcinoma of the thyroid (ATC)3. ....
The animal procedures described here were performed with the approval of the Animal Ethics Committee of West China Hospital, Sichuan University, Chengdu, Sichuan, China.
1. Induction of TBP mice
We induced mATC to investigate tumor growth, mouse survival time, and pathological characteristics. After induction, the mice were immediately sacrificed, and samples (thyroid, lung, and liver) were collected once one of the following conditions were found: 1) respiratory distress caused by tumor compression; 2) decreased appetite and abnormal vocalization; 3) unusually lethargy; and 4) body weight loss of over 20%. During the sampling process, we found that all mice (12/12) successfully formed tumors after induction. We.......
Critical steps within the protocol for thyroid tumor dissection
During dissection, the anatomical location of the thyroid gland needs to be correctly understood. The thyroid gland is a butterfly-shaped gland located on the dorsal side of the submandibular gland near the thyroid cartilage and the trachea. During the procedure, severing the blood arteries on both sides of the neck was carefully avoided.
Modification and troubleshooting of the mATC breed
This work was supported by the National Key Research Development Program of China (2021YFA1301203); the National Natural Science Foundation of China (82103031, 82103918, 81973408, 82272933); the Clinical Research Incubation Project, West China Hospital, Sichuan University (22HXFH019); the International Cooperation Project of Chengdu Municipal Science and Technology Bureau (2020-GH02-00017-HZ); Natural Science Foundation of Sichuan, 2022NSFSC1314; the "1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University" (ZYJC18035, ZYJC18025, ZYYC20003, ZYJC18003); and Sichuan Science and Technology Program (2023YFS0098).
....Name | Company | Catalog Number | Comments |
100x Citrate antigen retrieval solution (PH 6.0) | MXB | Cat# MVS-0101 | |
50x EDTA antigen retrieval solution(pH 9.5) | ZSGB-GIO | Cat# ZLI-9071 | |
Brafflox/wt mice | Collaboration with Institute of Life Science, eBond Pharmaceutical Technology Ltd, Chengdu, China | ||
Caspase-3 | Beyotime | Cat# AC033 | |
CD8 | Cell Signaling Technology | Cat# 98941; RRID:AB_2756376 | |
CD206 | Cell Signaling Technology | Cat# 24595; RRID:AB_2892682 | |
Chamber for anesthesia induction | RWDlifescience | ||
Enhanced DAB chromogenic kit | MXB | Cat# DAB-2031 | |
Eosin staining solution | ZSGB-GIO | Cat# ZLI-9613 | |
F4/80 | Abcam | Cat# 100790; RRID:AB_10675322 | |
Foxp3 | Cell Signaling Technology | Cat# 12653; RRID:AB_2797979 | |
Fully enclosed tissue dehydrator | Leica Biosystems | ASP300S | |
Hematoxylin staining solution | ZSGB-GIO | Cat# ZLI-9610 | |
HistoCore Arcadia fully automatic tissue embedding machine | Leica Biosystems | ||
Ki67 | Beyotime | Cat# AF1738 | |
Rotating Slicer | RWDlifescience | Â Minux S700 | |
SPlink detection kits (Biotin-Streptavidin HRP Detection Systems) | ZSGB-GIO | Cat# SP-9001 | |
TPO-cre/ERT2 mice | Collaboration with Institute of Life Science, eBond Pharmaceutical Technology Ltd, Chengdu, China | ||
Trp53flox/wt mice | Collaboration with Institute of Life Science, eBond Pharmaceutical Technology Ltd, Chengdu, China | ||
Ultrasonic cell crusher | Ningbo Xinyi Ultrasound Equipment Co., Ltd | JY92-IIN | |
Ultrasound gel | Keppler | KL-250 | |
Ultrasound system | VisualSonics | Vevo 3100 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved